Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

For Those Just Joining The Conversation

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (5) | Next 10 | Previous | Next
Scooter McCabe Member Profile
 
Followed By 35
Posts 1,239
Boards Moderated 0
Alias Born 04/13/18
160x600 placeholder
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/15/2020 5:06:59 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 9/14/2020 4:31:44 PM
SA Breaking News: ALYI - Alternet Systems revenue surging with new potential customers InvestorsHub NewsWire - 9/14/2020 10:10:04 AM
Traders News Source Identifies Tomorrows NASDAQ's InvestorsHub NewsWire - 9/3/2020 8:45:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/1/2020 5:34:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2020 2:57:56 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 9/1/2020 1:47:41 PM
MICROCAP DAILY - The Exciting Story of Puration Inc (OTCMKTS: PURA) InvestorsHub NewsWire - 8/26/2020 9:02:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 4:31:34 PM
Annual Report (10-k) Edgar (US Regulatory) - 8/14/2020 5:19:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2020 5:21:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 4:34:37 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 5:07:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 4:31:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:19:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2020 7:24:49 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 6/8/2020 5:28:53 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/8/2020 6:02:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2020 5:01:56 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/2/2020 8:01:17 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 5/15/2020 8:47:08 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/12/2020 6:00:59 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/30/2020 5:28:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 5:29:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2020 5:03:47 PM
Scooter McCabe   Tuesday, 06/02/20 11:03:07 AM
Re: None
Post # of 119272 
For Those Just Joining The Conversation

Welcome to the bullet point version of CYDY's history to date.

Cytodyn created with a focus on AIDs and HIV.

Cytodyn develops PRO 140 to treat HIV and HIV resistant strains.

PR0 140 is based on targeting the CCR5 antagonist receptor cells.

Cytodyn almost goes bankrupt, current CEO dumped his own money into the company and engages in some financing deals to save the company. (8 years ago)

Study of the drug and the CCR5 cell continues.

HIV study moves into phase 2. Dosages are increased and studied.

While the study is ongoing additional applications for the drug are discovered.

Trials for cancer, NASH, host vs graft start.

Cancer results promising, study extended to a basket trial for 22 solid tumor cancers.

HIV phase 3 starts, shares jump from .30 to 3.86. High fives and fist bumps reported.

Visibility attracts short sellers, day traders, speculators and late comers. Cue Tears For Fears "Everybody Wants To Rule The World."

FDA encouraging but slow progress.

COVID arrives, CEO announces investigation into COVID and the board shutters and calls him an idiot.

COVID actually becomes a big deal and PRO 140 now called Leronlimab actually shows solid results. The Board hails CEO.

Angry ex-board members and financing group that jumped off to early get unhappy and launch a sour grapes lawsuit. No current progress on their part.

A few notable short sellers take various pot shots at the company ranging from misleading research reports to OP-EDs.

An advertisement for class action lawsuit is floated by 5 firms. The daunting legal fire power that comes from one firm not actually having an office and the other being located in a mall next to a salad bar predictably dies a peasants death.

CYDY announces BLA submission, midterm results for COVID trial. Positive results, better than Remdsivir.

CYDY hosts a couple of conference calls that could have been just PRs. The natives get restless.

Remdsivir results mirror Ebola results, promising in the lab but a complete crap out in practical application.

CYDY files for its BLA to be decided upon in 6 months or less for HIV.

More patients for COVID study enrolled. Head to head study against Remdsivir ordered to chaos dunk Gilead.

Current Status....Waiting






Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (5) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences